Scott M. Coiante
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Scott M. Coiante
Scott M. Coiante is recorded as CFO at Aprea Therapeutics, Inc. (APRE). The proxy statement of Aprea Therapeutics, Inc. reports total compensation of $1,809,419 for Scott M. Coiante in fiscal 2019, including a base salary of $143,182.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Aprea Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Oren Gilad CEO
- Richard Peters, M.D., Ph.D. Chairman, Board Member
- John Hamill CFO
- Greg Korbel COO
- Bernd Seizinger Board Member
- Fouad Namouni, M.D. Board Member
- Gabriela Gruia Board Member
- Gabriela Gruia, M.D. Board Member
- Jean-Pierre Bizzari Board Member
- Marc Duey Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Aprea Therapeutics, Inc. (APRE) | Chief Financial Officer | $143,182 | $1,809,419 |
Recent activity
No call appearances or filed executive changes recorded yet.